International Journal of Hematology

, Volume 81, Issue 2, pp 176–177 | Cite as

Thromboprophylaxis with Reviparin in a Patient with Acquired Hemophilia

  • Antonio De Giorgi
  • Chiara Giannarelli
  • Ferdinando De Negri
  • Franco Carmassi
Letter to the Editor


Factor VIII Tranexamic Acid Autoimmune Hemolytic Anemia Direct Antiglobulin Test Inhibitor Titer 


  1. 1.
    Breddin HK. Reviparin sodium-a new low molecular weight heparin. Expert Opin Pharmacother. 2002;3:173–182.CrossRefGoogle Scholar
  2. 2.
    Shapiro SS, Hultin M. Acquired inhibitors to the blood coagulation factors. Semin Thromb Hemost. 1975;1:336–385.Google Scholar
  3. 3.
    Saud MA. Laboratory diagnosis of inhibitors. Semin Thromb Hemost. 2000;26:195–203.CrossRefGoogle Scholar
  4. 4.
    Feinstein DI. Immune coagulation disorders. In: Colman RW, Hirsh J, Marder VJ, et al, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, Pa: Lippincott Williams & Wilkins; 2001:1003–1020.Google Scholar
  5. 5.
    Lalwani RB, Stricker RB. Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency. Am J Med Sci. 1992;303:398–401.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acquired haemophilia. Eur J Haematol. 2002;68:307–309.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Schwartz RS, Begriel DA, Aledort LM, et al. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high dose intravenous immunoglobulin. Blood. 1995;86:797–804..PubMedGoogle Scholar

Copyright information

© The Japanese Society of Hematology 2005

Authors and Affiliations

  • Antonio De Giorgi
    • 2
  • Chiara Giannarelli
    • 1
  • Ferdinando De Negri
    • 1
  • Franco Carmassi
    • 1
  1. 1.Department of Internal MedicineUniversity of PisaPisaItaly
  2. 2.Dept of Emergency Medicine and First AidS Chiara HospitalPisaItaly

Personalised recommendations